TransMedics Group Inc.
TMDX | NASDAQ
$87.29
+$0.87 (+1.01%)
At close: Sep 21, 2026, 4:00 PM ET
$87.48
+$0.19 (+0.22%)
Pre-market:
Sep 22, 2026, 4:01 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 605.49M | 441.54M | 241.62M | 93.46M | 30.26M | 25.64M |
Cost of Revenue | 242.69M | 179.46M | 87.53M | 28.19M | 9.1M | 9M |
Gross Profit | 362.81M | 262.08M | 154.09M | 65.27M | 21.16M | 16.64M |
Operating Income | 108.58M | 37.5M | -28.73M | -31.44M | -39.43M | -26.38M |
Interest Income | n/a | n/a | 12.5M | 900K | n/a | 1.65M |
Pretax Income | 107.52M | 35.78M | -26.67M | -36.17M | -44.18M | -28.72M |
Net Income | 190.29M | 35.46M | -25.03M | -36.23M | -44.22M | -28.75M |
Selling & General & Admin | 185.17M | 168.62M | 119.55M | 69.9M | 38.28M | 24.19M |
Research & Development | 69.06M | 55.97M | 63.27M | 26.81M | 22.3M | 18.83M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 254.22M | 224.59M | 182.82M | 96.71M | 60.59M | 43.02M |
Interest Expense | 13.78M | 14.41M | 10.79M | 3.73M | 3.87M | 3.99M |
Selling & Marketing Expenses | 4.32M | n/a | n/a | 18.21M | n/a | n/a |
Cost & Expenses | 496.91M | 404.04M | 270.35M | 124.9M | 69.69M | 52.02M |
Income Tax Expense | -82.77M | 316K | -1.64M | 66K | 36K | 32K |
Shares Outstanding (Basic) | 33.99M | 33.23M | 32.52M | 29.56M | 27.62M | 24.7M |
Shares Outstanding (Diluted) | 40.54M | 35.22M | 32.52M | 29.56M | 27.62M | 24.7M |
EPS (Basic) | 5.60 | 1.07 | -0.77 | -1.23 | -1.60 | -1.16 |
EPS (Diluted) | 4.87 | 1.01 | -0.77 | -1.23 | -1.60 | -1.16 |
EBITDA | 148.49M | 69.95M | -7.7M | -28.96M | -38.49M | -23.15M |
EBIT | 121.3M | 50.19M | -15.88M | -32.44M | -40.31M | -24.73M |
Depreciation & Amortization | 27.19M | 19.76M | 8.18M | 3.48M | 1.82M | 1.58M |
Add to Watchlist
Select watchlists to add or remove TMDX